Tris Pharma

Tris Pharma is a privately held pharmaceutical company known for developing and marketing treatments for ADHD (like Dyanavel XR, amphetamine-based) and other conditions. The company is also working on investigational drugs like Cebranopadol. UpGuard continuously monitors the security posture of Tris Pharma using open-source, commercial, and proprietary threat intelligence feeds. Our analysis is centered on objective, externally verifiable information.

Tris Pharma Security Rating

X
---
/ 950
Tris Pharma's security rating is based on the analysis of their external attack surface. The higher the rating, the better their security posture. Start a free trial to get a more in-depth risk assessment for Tris Pharma.

Company info

Tris Pharma
Company
Tris Pharma
Employees
Location
CEO
Last updated
Last updated
Industries
Last updated today

Tris Pharma Vendor Risk Report

This vendor risk report is based on UpGuard’s continuous monitoring of Tris Pharma's security posture using open-source, commercial, and proprietary threat intelligence feeds. The results are summarized into a security rating based on the analysis of hundreds of individual checks across five risk categories: website security, email security, phishing & malware, brand & reputation risk, and network security.

Last updated today

Tris Pharma Data Breaches, Cybersecurity Incidents and News

Security incidents, news, and data leaks relating to Tris Pharma.

Security reports related to Tris Pharma

Compare Tris Pharma's security performance with other companies in their industry.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating